Table 1 Baseline characteristics of patients who underwent kidney biopsy and their baseline eosinophilia on hematology
From: Eosinophilia and risk of incident end stage kidney disease
Demographics | No Eosinophilia ≤ 4% (n = 113) | Peripheral Eosinophilia >  4% (n = 65) | P-value |
|---|---|---|---|
Female | 56 (50%) | 21 (32%) | 0.025 |
Age, mean (SD), y | 51 (17) | 53 (18) | 0.51 |
Race | |||
 White | 57 (50%) | 31 (48%) | 0.55 |
 Black | 47 (42%) | 30 (46%) |  |
 Other | 9 (8%) | 4 (6%) |  |
Asthma | 17 (15%) | 8 (12%) | 0.61 |
Filarial Disease | 0 (0%) | 1 (2%) | 0.19 |
HIV | 15 (14%) | 4 (6%) | 0.13 |
Transplant | 18 (16%) | 8 (13%) | 0.54 |
HTN | 80 (71%) | 42 (70%) | 0.84 |
Baseline eGFR stagea | |||
 I | 63 (56) | 49 (76) | 0.013 |
 II | 35 (31) | 9 (13) |  |
 III | 10 (8) | 3 (5) |  |
 IV | 1 (1) | 3 (5) |  |
 early V | 4 (4) | 1 (1) |  |
Diabetes | 19 (17) | 15 (23) | 0.32 |
Mean UPCR (SD), g | 3.4 (9.9) | 3.2 (4.5) | 0.86 |
Mean serum Cr at biopsy (SD), mg/dl | 2.9 (2.9) | 3.9 (3.9) | 0.043 |
Indication for kidney biopsy | |||
 AKI | 45 (40) | 23 (37) | 0.03 |
 CKD | 5 (4) | 0 (0) |  |
 AKOCKD | 39 (27) | 35 (53) |  |
 Nephrotic Syndrome | 24 (21) | 7 (10) |  |